However, it is unclear whether renoprotection was mechanistically linked to the activation of HIF-1α or, rather, of the HIF-2α isoform, which is a key regulator of renal erythropoiesis [21,52] and a potential new target for the treatment of anemia in chronic kidney disease [53]. Here, HIF1A is linked to chronic kidney disease.